Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berwyn, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Virpax Pharmaceuticals, Inc. has filed 278 SEC EDGAR filings since 05 Apr 2018

SEC filing history

Showing 1-12 of 12 matching filings.

Per page
25
Current page
1
10-Q File 001-40064

QUARTERLY REPORT

Filing date
12 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
13 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
07 Dec 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
12 May 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
09 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
15 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
16 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
15 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
10 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
17 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .